Anaphylaxis: Mechanisms of mast cell activation

Chemical Immunology and Allergy

Volumn 95, Issue , 2010, Pages 45-66

  Kalesnikoff, Janet ^a   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; OPIATE; STEM CELL FACTOR; VANCOMYCIN;

ANAPHYLAXIS; BASOPHIL; CALCIUM TRANSPORT; CELL ACTIVATION; CELL AGGREGATION; CELL SURVIVAL; DISEASE MODEL; GENE MUTATION; HUMAN; MAST CELL; MEDIATOR RELEASE; MEMBRANE FUSION; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANAPHYLAXIS; ANIMALS; BASOPHILS; CELL DEGRANULATION; DISEASE MODELS, ANIMAL; HUMANS; MAST CELLS; MICE;

EID: 77954849436     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000315937     Document Type: Review

References (77)

1. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, Leung DY, Lotvall J, Marone G, Metcalfe DD, Muller U, Rosenwasser LJ, Sampson HA, Schwartz LB, van Hage M, Walls AF: Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 2007;120:S2-S24.
2. Peavy RD, Metcalfe DD: understanding the mechanisms of anaphylaxis. Curr Opin Allergy Clin Immunol 2008;8:310-315.
3. Bochner BS, Lichtenstein LM: Anaphylaxis. N Engl J Med 1991;324:1785-1790.
4. Finkelman FD: Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 2007;120:506-515.
5. Galli SJ: Pathogenesis and management of anaphylaxis: current status and future challenges. J Allergy Clin Immunol 2005;115:571-574.
6. Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M: Mast cells as 'tunable' effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005;23:749-786.
7. Gould HJ, Sutton BJ: IgE in allergy and asthma today. Nat Rev Immunol 2008;8:205-217.
8. Kraft S, Kinet JP: New developments in FceRI regulation, function and inhibition. Nat Rev Immunol 2007;7:365-378.
9. MacGlashan D Jr: IgE receptor and signal transduction in mast cells and basophils. Curr Opin Immunol 2008;20:717-723.
10. Simons FE: Anaphylaxis. J Allergy Clin Immunol 2008;121:S402-S407.
11. Kitamura Y, Go S, Hatanaka K: Decrease of mast cells in W/W v mice and their increase by bone marrow transplantation. Blood 1978;52:447-452.
12. Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ: Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 2005;167: 835-848.
13. Nigrovic PA, Gray DH, Jones T, Hallgren J, Kuo FC, Chaletzky B, Gurish M, Mathis D, Benoist C, Lee DM: genetic inversion in mast cell-deficient Wsh mice interrupts Corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol 2008;173: 1693-16701.
14. Wolters PJ, Mallen-St Clair J, Lewis CC, Villalta SA, Baluk P, Erle DJ, Caughey GH: Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient KitW-sh/KitW-sh sash mice. Clin Exp Allergy 2005;35:82-88.
15. Kalesnikoff J, Galli SJ: New developments in mast cell biology. Nat Immunol 2008;9:1215-1223.
16. Musch W, Wege AK, Mannel DN, Hehlgans T: Generation and characterization of α-chymase-Cre transgenic mice. Genesis 2008;46:163-166.
17. Scholten J, Hartmann K, Gerbaulet A, Krieg T, Muller W, Testa G, Roers A: Mast cell-specific Cre/ loxP-mediated recombination in vivo. Transgenic Res 2008;17:307-315.
18. Ha TY, Reed ND, Crowle PK: Immune response potential of mast cell-deficient W/Wv mice. Int Arch Allergy Appl Immunol 1986;80:85-94.
19. Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P: Active anaphylaxis in IgEdeficient mice. Nature 1994;370:367-370.
20. Dombrowicz D, Flamand V, Miyajima I, Ravetch JV, Galli SJ, Kinet JP: Absence of FceRI α-chain results in upregulation of FceRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FceRI and FceRIII for limiting amounts of FcR α-and α-chains. J Clin Invest 1997; 99:915-925.
21. Tsujimura Y, Obata K, Mukai K, Shindou H, Yoshida M, Nishikado H, Kawano Y, Minegishi Y, Shimizu T, Karasuyama H: Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 2008;28:581-589.
22. Miyajima I, Dombrowicz D, Martin TR, Ravetch JV, Kinet JP, Galli SJ: Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FceRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE-or IgG1-dependent passive anaphylaxis. J Clin Invest 1997;99:901-914.
23. Kawakami T, Galli SJ: Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002;2:773-786.
24. Grayson MH, Cheung D, Rohlfing MM, Kitchens R, Spiegel DE, Tucker J, Battaile JT, Alevy Y, Yan L, Agapov E, Kim EY, Holtzman MJ: Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia. J Exp Med 2007;204:2759-2769.
25. Gilfillan AM, Peavy RD, Metcalfe DD: Amplification mechanisms for the enhancement of antigen-mediated mast cell activation. Immunol Res 2008.
26. Rivera J, Fierro NA, Olivera A, Suzuki R: New insights on mast cell activation via the high affinity receptor for IgE. Adv Immunol 2008;98:85-120.
27. Liu Y, Zhu M, Nishida K, Hirano T, Zhang W: An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response. J Exp Med 2007;204: 93-103.
28. Hong H, Kitaura J, Xiao W, Horejsi V, Ra C, Lowell CA, Kawakami Y, Kawakami T: The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood 2007;110:2511-2519.
29. Baba Y, Nishida K, Fujii Y, Hirano T, Hikida M, Kurosaki T: Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat Immunol 2008;9:81-88.
30. Vig M, DeHaven WI, Bird GS, Billingsley JM, Wang H, Rao PE, Hutchings AB, Jouvin MH, Putney JW, Kinet JP: Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of storeoperated calcium release-activated calcium channels. Nat Immunol 2008;9:89-96.
31. Vennekens R, Olausson J, Meissner M, Bloch W, Mathar I, Philipp SE, Schmitz F, Weissgerber P, Nilius B, Flockerzi V, Freichel M: Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nat Immunol 2007;8:312-320.
32. Guo Z, Turner C, Castle D: Relocation of the t-SNARE SNAP-23 from lamellipodia-like cell surface projections regulates compound exocytosis in mast cells. Cell 1998;94:537-548.
33. Logan MR, Odemuyiwa SO, Moqbel R: Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. J Allergy Clin Immunol 2003;111:923-932.
34. Puri N, Roche PA: Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci USA 2008;105:2580-2585.
35. Tiwari N, Wang CC, Brochetta C, Ke G, Vita F, Qi Z, Rivera J, Soranzo MR, Zabucchi G, Hong W, Blank U: VAMP-8 segregates mast cell-preformed mediator exocytosis from cytokine trafficking pathways. Blood 2008;111:3665-3674.
36. Sander LE, Frank SP, Bolat S, Blank U, Galli T, Bigalke H, Bischoff SC, Lorentz A: Vesicle-associated membrane protein (VAMP)-7 and VAMP-8, but not VAMP-2 or VAMP-3, are required for activationinduced degranulation of mature human mast cells. Eur J Immunol 2008;38:855-863.
37. Suzuki K, Verma IM: Phosphorylation of SNAP-23 by IκB kinase 2 regulates mast cell degranulation. Cell 2008;134:485-495.
38. Kalesnikoff J, Rios EJ, Chen CC, Alejandro Barbieri M, Tsai M, Tam SY, Galli SJ: Roles of RabGEF1/ Rabex-5 domains in regulating FceRI surface expression and FceRI-dependent responses in mast cells. Blood 2007;109:5308-5317.
39. Rios EJ, Piliponsky AM, Ra C, Kalesnikoff J, Galli SJ: Rabaptin-5 regulates receptor expression and functional activation in mast cells. Blood 2008;112: 4148-4157.
40. Leung WH, Bolland S: The inositol 5́-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production. J Immunol 2007;179:95-102.
41. Ong CJ, Ming-Lum A, Nodwell M, Ghanipour A, Yang L, Williams DE, Kim J, Demirjian L, Qasimi P, Ruschmann J, Cao LP, Ma K, Chung SW, Duronio V, Andersen RJ, Krystal G, Mui AL: Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood 2007;110:1942-1949.
42. Bansal G, Xie Z, Rao S, Nocka KH, Druey KM: Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13. Nat Immunol 2008;9:73-80.
43. Bansal G, DiVietro JA, Kuehn HS, Rao S, Nocka KH, Gilfillan AM, Druey KM: RGS13 controls G protein-coupled receptor-evoked responses of human mast cells. J Immunol 2008;181:7882-7890.
44. Saxon A, Kepley C, Zhang K: 'Accentuate the negative, eliminate the positive': engineering allergy therapeutics to block allergic reactivity through negative signaling. J Allergy Clin Immunol 2008; 121:320-325.
45. Mertsching E, Bafetti L, Hess H, Perper S, Giza K, Allen LC, Negrou E, Hathaway K, Hopp J, Chung J, Perret D, Shields M, Saxon A, Kehry MR: A mouse FceFce protein that inhibits mast cells through activation of FceRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases. J Allergy Clin Immunol 2008; 121:441-447.
46. Conroy MC, Adkinson NF Jr, Lichtenstein LM: Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release. J Immunol 1977;118:1317-1321.
47. Malveaux FJ, Conroy MC, Adkinson NF Jr, Lichtenstein LM: IgE receptors on human basophils. relationship to serum IgE concentration. J Clin Invest 1978;62:176-181.
48. Stallman PJ, Aalberse RC: Quantitation of basophilbound IgE in atopic and nonatopic subjects. Int Arch Allergy Appl Immunol 1977;54:114-120.
49. Furuichi K, Rivera J, Isersky C: The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression. Proc Natl Acad Sci USA 1985;82:1522-1525.
50. Quarto R, Kinet JP, Metzger H: Coordinate synthesis and degradation of the α-, α-and α-subunits of the receptor for immunoglobulin E. Mol Immunol 1985;22:1045-1051. (Pubitemid 16248534)
51. Hsu C, MacGlashan D Jr: IgE antibody up-regulates high affinity IgE binding on murine bone marrowderived mast cells. Immunol Lett 1996;52:129-134.
52. Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, Kinet JP, Galli SJ: IgE enhances mouse mast cell FceRI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 1997;185:663-672.
53. Matsuda K, Piliponsky AM, Iikura M, Nakae S, Wang EW, Dutta SM, Kawakami T, Tsai M, Galli SJ: Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response. J Allergy Clin Immunol 2005;116:1357-1363.
54. James LC, Roversi P, Tawfik DS: Antibody multispecificity mediated by conformational diversity. Science 2003;299:1362-1367.
55. Kepley CL, Youssef L, Andrews RP, Wilson BS, Oliver JM: Syk deficiency in nonreleaser basophils. J Allergy Clin Immunol 1999;104:279-284.
56. Vonakis BM, Gibbons S Jr, Sora R, Langdon JM, MacDonald SM: Src homology 2 domain-containing inositol 5́ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J Allergy Clin Immunol 2001;108:822-831.
57. Yamashita Y, Charles N, Furumoto Y, Odom S, Yamashita T, Gilfillan AM, Constant S, Bower MA, Ryan JJ, Rivera J: Cutting edge: genetic variation influences FceRI-induced mast cell activation and allergic responses. J Immunol 2007;179:740-743.
58. Hernandez-Hansen V, Mackay GA, Lowell CA, Wilson BS, Oliver JM: The Src kinase Lyn is a negative regulator of mast cell proliferation. J Leukoc Biol 2004;75:143-151.
59. Odom S, Gomez G, Kovarova M, Furumoto Y, Ryan JJ, Wright HV, Gonzalez-Espinosa C, Hibbs ML, Harder KW, Rivera J: Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med 2004;199:1491-1502.
60. Hibbs ML, Tarlinton DM, Armes J, Grail D, Hod gson G, Maglitto R, Stacker SA, Dunn AR: Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 1995;83:301-311.
61. Nishizumi H, Yamamoto T: Impaired tyrosine phosphorylation and Ca2+ mobilization, but not degranulation, in Lyn-deficient bone marrow-derived mast cells. J Immunol 1997;158:2350-2355.
62. Costa JJ, Demetri GD, Harrist TJ, Dvorak AM, Hayes DF, Merica EA, Menchaca DM, Gringeri AJ, Schwartz LB, Galli SJ: Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia and functional activation in vivo. J Exp Med 1996;183:2681-2686.
63. Brockow K, Jofer C, Behrendt H, Ring J: Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008;63;226-232.
64. Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, Metcalfe DD: Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with 'idiopathic' anaphylaxis. Blood 2007;110:2331-2333.
65. Tilley SL, Wagoner VA, Salvatore CA, Jacobson MA, Koller BH: Adenosine and inosine increase cutaneous vasopermeability by activating A3 receptors on mast cells. J Clin Invest 2000;105:361-367.
66. Laffargue M, Calvez R, Finan P, Trifilieff A, Barbier M, Altruda F, Hirsch E, Wymann MP: Phosphoinositide 3-kinase α-is an essential amplifier of mast cell function. Immunity 2002;16:441-451.
67. Feoktistov I, Biaggioni I: Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 1995;96:1979-1986.
68. Hua X, Kovarova M, Chason KD, Nguyen M, Koller BH, Tilley SL: Enhanced mast cell activation in mice deficient in the A2b adenosine receptor. J Exp Med 2007;204:117-128.
69. Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Dikov MM, Blackburn MR, Biaggioni I, Feoktistov I: Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells. J Immunol 2008;180:7212-7220.
70. Livingston M, Heaney LG, Ennis M: Adenosine, inflammation and asthma -a review. Inflamm Res 2004;53:171-178.
71. Polosa R, Holgate ST: Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation. Curr Drug Targets 2006;7:699-706.
72. Spicuzza L, Di Maria G, Polosa R: Adenosine in the airways: implications and applications. Eur J Pharmacol 2006;533:77-88.
73. Holgate ST, Church MK, Lichtenstein LM. Allergy. New York, Elsevier Health Sciences, 2006.
74. Golden DB: Insect allergy in children. Curr Opin Allergy Clin Immunol 2006;6:289-293.
75. Sampson HA, Mendelson L, Rosen JP: Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380-384.
76. Vercelli D: Genetic regulation of IgE responses: Achilles and the tortoise. J Allergy Clin Immunol 2005;116:60-64.
77. Strait RT, Morris SC, Finkelman FD: IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FceRIIb cross-linking. J Clin Invest 2006;116:833-841.